title: Organelle targeting: third level of drug targeting.
abstract: Drug discovery and drug delivery are two main aspects for treatment of a variety of disorders. However, the real bottleneck associated with systemic drug administration is the lack of target-specific affinity toward a pathological site, resulting in systemic toxicity and innumerable other side effects as well as higher dosage requirement for efficacy. An attractive strategy to increase the therapeutic index of a drug is to specifically deliver the therapeutic molecule in its active form, not only into target tissue, nor even to target cells, but more importantly, into the targeted organelle, ie, to its intracellular therapeutic active site. This would ensure improved efficacy and minimize toxicity. Cancer chemotherapy today faces the major challenge of delivering chemotherapeutic drugs exclusively to tumor cells, while sparing normal proliferating cells. Nanoparticles play a crucial role by acting as a vehicle for delivery of drugs to target sites inside tumor cells. In this review, we spotlight active and passive targeting, followed by discussion of the importance of targeting to specific cell organelles and the potential role of cell-penetrating peptides. Finally, the discussion will address the strategies for drug/DNA targeting to lysosomes, mitochondria, nuclei and Golgi/endoplasmic reticulum.
authors.affiliation: Department of Cell and Molecular Biology, BV Patel Pharmaceutical Education and Research Development (PERD) Centre, Gujarat, India.
authors.forename: Niraj M
authors.initials: NM
authors.lastname: Sakhrani
authors.forename: Harish
authors.initials: H
authors.lastname: Padh
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002467:Cell Nucleus / Q000187:drug effects; D057846:Cell-Penetrating Peptides / Q000008:administration & dosage; D016503:Drug Delivery Systems; D004705:Endocytosis; D004721:Endoplasmic Reticulum / Q000187:drug effects; D006056:Golgi Apparatus / Q000187:drug effects; D006801:Humans; D008247:Lysosomes / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy*; D015388:Organelles / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D057846:Cell-Penetrating Peptides
keywords: cancer chemotherapy; cell penetrating peptides; intracellular drug delivery; therapeutic index
references.citation: Nat Rev Mol Cell Biol. 2011 Jul 22;12(8):517-33
references.pmid: 21779028
references.citation: J Cell Biol. 2003 May 26;161(4):673-7
references.pmid: 12771123
references.citation: J Transl Med. 2013 Mar 22;11:74
references.pmid: 23517638
references.citation: Biochem Biophys Res Commun. 2002 Nov 1;298(3):439-49
references.pmid: 12413961
references.citation: Blood. 2004 Oct 1;104(7):1961-9
references.pmid: 15191951
references.citation: Eur J Biochem. 1999 Aug;263(3):709-16
references.pmid: 10469134
references.citation: J Cell Biol. 2005 Jan 31;168(3):477-88
references.pmid: 15668298
references.citation: J Control Release. 2008 May 22;128(1):32-40
references.pmid: 18395283
references.citation: Microbiol Mol Biol Rev. 2001 Dec;65(4):570-94, table of contents
references.pmid: 11729264
references.citation: FEBS Lett. 2004 Jan 30;558(1-3):63-8
references.pmid: 14759517
references.citation: Biochim Biophys Acta. 2008 Dec;1786(2):126-38
references.pmid: 18440319
references.citation: Mol Cell Proteomics. 2005 Feb;4(2):133-43
references.pmid: 15579476
references.citation: Nat Rev Drug Discov. 2012 Oct;11(10):751-61
references.pmid: 22935759
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: Curr Drug Deliv. 2005 Oct;2(4):369-81
references.pmid: 16305440
references.citation: Traffic. 2002 May;3(5):311-20
references.pmid: 11967125
references.citation: Mol Ther. 2005 Sep;12(3):510-8
references.pmid: 15953766
references.citation: J Am Chem Soc. 2010 Feb 10;132(5):1517-9
references.pmid: 20085324
references.citation: Bioconjug Chem. 2005 Sep-Oct;16(5):1176-80
references.pmid: 16173795
references.citation: Immunol Cell Biol. 2002 Apr;80(2):119-30
references.pmid: 11940112
references.citation: J Biol Chem. 2003 Sep 5;278(36):34141-9
references.pmid: 12773529
references.citation: J Biol Chem. 2001 Feb 23;276(8):5836-40
references.pmid: 11084031
references.citation: J Control Release. 2001 Aug 10;75(3):401-8
references.pmid: 11489326
references.citation: Med Res Rev. 2002 May;22(3):225-50
references.pmid: 11933019
references.citation: Nature. 1998 Apr 9;392(6676):543-4
references.pmid: 9560144
references.citation: Mol Cell Neurosci. 1999 Aug;14(2):121-8
references.pmid: 10479410
references.citation: Cancer Res. 2001 Jun 15;61(12):4851-7
references.pmid: 11406562
references.citation: In Vivo. 2007 Mar-Apr;21(2):215-26
references.pmid: 17436569
references.citation: Postepy Biochem. 2006;52(2):145-56
references.pmid: 17078504
references.citation: J Leukoc Biol. 2002 Dec;72(6):1092-108
references.pmid: 12488490
references.citation: Trends Pharmacol Sci. 2000 Mar;21(3):99-103
references.pmid: 10689363
references.citation: J Biol Chem. 2002 Feb 22;277(8):6504-10
references.pmid: 11724773
references.citation: Bioessays. 2003 Sep;25(9):868-77
references.pmid: 12938176
references.citation: Cancer Res. 2000 Oct 1;60(19):5349-53
references.pmid: 11034069
references.citation: Adv Drug Deliv Rev. 2000 Mar 30;41(2):235-50
references.pmid: 10699318
references.citation: Mol Ther. 2003 Apr;7(4):550-7
references.pmid: 12727119
references.citation: Anal Biochem. 2005 Oct 1;345(1):55-65
references.pmid: 16137634
references.citation: Int J Gynecol Cancer. 2009 Oct;19(7):1281-3
references.pmid: 19820391
references.citation: Cell. 1991 Feb 8;64(3):615-23
references.pmid: 1991323
references.citation: Gene Ther. 2000 Jan;7(1):31-4
references.pmid: 10680013
references.citation: J Cell Biochem. 2010 Dec 1;111(5):1082-6
references.pmid: 21053280
references.citation: Methods Mol Biol. 2010;624:25-37
references.pmid: 20217587
references.citation: Exp Physiol. 2003 Jan;88(1):57-64
references.pmid: 12525855
references.citation: Cell. 2000 Mar 3;100(5):551-60
references.pmid: 10721992
references.citation: J Biomed Sci. 2002;9(6 Pt 1):534-41
references.pmid: 12372991
references.citation: Science. 1999 Sep 3;285(5433):1569-72
references.pmid: 10477521
references.citation: Int Immunopharmacol. 2003 Mar;3(3):319-28
references.pmid: 12639809
references.citation: Traffic. 2007 Jul;8(7):848-66
references.pmid: 17587406
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: J Neurochem. 2001 Nov;79(4):719-25
references.pmid: 11723164
references.citation: J Gene Med. 2005 Aug;7(8):992-1009
references.pmid: 15920783
references.citation: J Biol Chem. 2005 Jan 21;280(3):2352-60
references.pmid: 15533943
references.citation: J Control Release. 2010 Dec 1;148(2):135-46
references.pmid: 20797419
references.citation: Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11307-11
references.pmid: 8248244
references.citation: J Cell Biol. 2002 Sep 16;158(6):1119-31
references.pmid: 12221069
references.citation: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):5760-2
references.pmid: 11983877
references.citation: Int J Cancer. 2010 Dec 15;127(12):2893-917
references.pmid: 21351269
references.citation: Cancer Res. 2006 Sep 15;66(18):8927-30
references.pmid: 16982728
references.citation: J Control Release. 2011 May 10;151(3):220-8
references.pmid: 21078351
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7297-301
references.pmid: 7638184
references.citation: Biochem J. 2011 Mar 1;434(2):219-31
references.pmid: 21143193
references.citation: J Cell Sci. 2010 Apr 15;123(Pt 8):1183-9
references.pmid: 20356929
references.citation: Int J Biochem Cell Biol. 2012 Nov;44(11):1872-6
references.pmid: 22721754
references.citation: J Control Release. 2005 Jan 20;102(1):247-53
references.pmid: 15653149
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1972-7
references.pmid: 12571356
references.citation: Pharmacol Rev. 2006 Mar;58(1):32-45
references.pmid: 16507881
references.citation: FASEB J. 2006 Sep;20(11):1775-84
references.pmid: 16940149
references.citation: J Biol Chem. 2009 Aug 14;284(33):22411-22425
references.pmid: 19531493
references.citation: Cancer Res. 2003 Jun 15;63(12):3154-61
references.pmid: 12810643
references.citation: Biochim Biophys Acta. 2009 Apr;1793(4):625-35
references.pmid: 18977398
references.citation: Indian J Biochem Biophys. 2004 Apr-Jun;41(2-3):69-80
references.pmid: 22900333
references.citation: Curr Opin Cell Biol. 2007 Aug;19(4):417-25
references.pmid: 17631994
references.citation: Biochem J. 1955 Aug;60(4):604-17
references.pmid: 13249955
references.citation: J Oncol. 2010;2010:723798
references.pmid: 20454584
references.citation: Circ Res. 2007 Jun 8;100(11):1626-33
references.pmid: 17495229
references.citation: Int J Pharm. 2007 Mar 1;331(2):211-4
references.pmid: 17187949
references.citation: Anal Biochem. 2005 Mar 15;338(2):284-93
references.pmid: 15745749
references.citation: Mol Biol Cell. 2005 Jun;16(6):2999-3009
references.pmid: 15814838
references.citation: Adv Drug Deliv Rev. 2001 Jul 2;49(1-2):121-5
references.pmid: 11377807
references.citation: Cancer Invest. 2002;20(5-6):693-9
references.pmid: 12197225
references.citation: Int J Biochem Cell Biol. 2012 Jun;44(6):869-75
references.pmid: 22387312
references.citation: Biochem J. 2007 Oct 15;407(2):285-92
references.pmid: 17627607
references.citation: Ann N Y Acad Sci. 2006 Oct;1082:18-26
references.pmid: 17145920
references.citation: Biomaterials. 2007 Jun;28(18):2876-84
references.pmid: 17363053
references.citation: Physiology (Bethesda). 2010 Apr;25(2):102-15
references.pmid: 20430954
references.citation: J Clin Invest. 1996 Dec 15;98(12):2838-44
references.pmid: 8981932
references.citation: Swiss Med Wkly. 2002 May 4;132(17-18):211-22
references.pmid: 12087487
references.citation: Annu Rev Immunol. 1999;17:593-623
references.pmid: 10358769
references.citation: J Biol Chem. 2004 Jan 2;279(1):772-8
references.pmid: 14578359
references.citation: Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1864-8
references.pmid: 1672046
references.citation: Int J Mol Sci. 2012;13(2):1886-918
references.pmid: 22408430
references.citation: Exp Cell Res. 2004 Jul 1;297(1):285-93
references.pmid: 15194443
references.citation: Science. 2001 Feb 16;291(5507):1304-51
references.pmid: 11181995
references.citation: Mol Pharm. 2012 Feb 6;9(2):299-309
references.pmid: 22171592
references.citation: Adv Drug Deliv Rev. 2007 Aug 10;59(8):748-58
references.pmid: 17659804
references.citation: Biotechnol Appl Biochem. 2004 Oct;40(Pt 2):157-65
references.pmid: 14709162
references.citation: Traffic. 2000 Nov;1(11):836-51
references.pmid: 11208074
references.citation: Mitochondrion. 2005 Oct;5(5):352-8
references.pmid: 16154389
references.citation: Mol Biol Cell. 2007 Mar;18(3):1073-82
references.pmid: 17215520
references.citation: J R Soc Interface. 2010 Feb 6;7 Suppl 1:S55-66
references.pmid: 19940000
references.citation: J Biol Chem. 2000 Oct 20;275(42):32438-43
references.pmid: 10961984
references.citation: Curr Cancer Drug Targets. 2012 May;12(4):316-28
references.pmid: 22385512
references.citation: Rejuvenation Res. 2010 Apr-Jun;13(2-3):229-36
references.pmid: 20345279
references.citation: Pharm Res. 1998 Feb;15(2):334-7
references.pmid: 9523323
references.citation: Nature. 2001 Feb 15;409(6822):860-921
references.pmid: 11237011
references.citation: Mitochondrion. 2004 Mar;3(4):229-44
references.pmid: 16120357
references.citation: Leuk Res. 2009 Nov;33(11):1440-7
references.pmid: 19595459
references.citation: J Struct Biol. 2006 Oct;156(1):29-40
references.pmid: 16529947
references.citation: J Biol Chem. 1998 Mar 27;273(13):7507-11
references.pmid: 9516451
references.citation: Int J Pharm. 2008 Jan 4;346(1-2):143-50
references.pmid: 17640835
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):97-110
references.pmid: 18227410
references.citation: Pharmaceuticals (Basel). 2010 Mar 11;3(3):600-620
references.pmid: 27713270
references.citation: J Natl Cancer Inst. 2000 Jul 5;92(13):1042-53
references.pmid: 10880547
references.citation: Histol Histopathol. 2006 Aug;21(8):899-913
references.pmid: 16691542
references.citation: Nat Rev Drug Discov. 2010 Jan;9(1):29-42
references.pmid: 20043027
references.citation: Diabetes. 2004 Feb;53 Suppl 1:S96-102
references.pmid: 14749273
references.citation: J Biophys. 2011;2011:414729
references.pmid: 21687343
references.citation: Proc Natl Acad Sci U S A. 1987 Aug;84(15):5444-8
references.pmid: 3474661
references.citation: J Drug Target. 2008 Aug;16(7):578-85
references.pmid: 18686127
references.citation: J Neurooncol. 2009 Jun;93(2):285-6
references.pmid: 19048187
references.citation: Aliment Pharmacol Ther. 1997 Dec;11 Suppl 3:109-15
references.pmid: 9467985
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2200-5
references.pmid: 19164757
references.citation: Science. 1956 Feb 24;123(3191):309-14
references.pmid: 13298683
references.citation: Nature. 2002 Dec 5;420(6915):520-62
references.pmid: 12466850